Group 1: Medline (MDLN) - Medline opened at $35 per share, a 20.69% increase from the offering price, and closed at $41, marking a 41.38% rise with a total market capitalization of $75.563 billion [2][4] - The company issued 216 million shares at $29 each, raising $6.265 billion, with plans to use the funds for debt repayment and general corporate purposes [4] - Medline is a leading global manufacturer and distributor of medical supplies, producing hundreds of thousands of consumable medical products including surgical gloves, gowns, dressings, and surgical packs [4] Group 2: Andersen (ANDG) - Andersen opened at $21 per share, a 31.25% increase from the offering price, and closed at $23.5, reflecting a 46.88% rise with a total market capitalization of $2.569 billion [5][7] - The company issued 11 million shares at $16 each, raising $176 million, with plans to invest in technology, infrastructure, training, and potential strategic acquisitions [7] - Andersen provides independent tax, valuation, and financial consulting services to individuals, family offices, businesses, and institutional clients, having served 11,900 clients as of September 30, 2025 [7] Group 3: SPACs - Churchill Capital XI (CCXIU) raised $360 million, while Iron Horse Acquisition II (IRHOU) raised $200 million [8] - Churchill Capital XI, initiated by Michael Klein, aims to target companies with stable revenues and strong management teams [8] - Iron Horse Acquisition II, led by Jose Bengochea, focuses on the media and entertainment industry, particularly in music, animation, and artificial intelligence [8]

Core Viewpoint - Medline Inc., a major U.S. healthcare company focused on medical supplies, is seeking to raise up to $5.37 billion through an IPO, potentially becoming the largest private equity-backed IPO in history and the largest U.S. IPO of the year [1][2]. Company Overview - Medline specializes in the production and distribution of medical supplies such as gloves, isolation gowns, surgical apparel, and examination tables for hospitals and healthcare professionals [4]. - The company was privatized in 2021 in a $34 billion deal led by private equity firms Blackstone, Carlyle Group, and Hellman & Friedman, marking one of the largest leveraged buyouts in financial history [4]. - Medline has a history dating back to 1910 and is one of the largest private manufacturers and distributors of medical and surgical supplies in North America and globally, with annual sales exceeding $20 billion [4]. IPO Details - The company plans to issue 179 million shares at a price range of $26 to $30 per share, with a maximum valuation of $55.3 billion [1][2]. - If priced at the top of the range, the IPO would raise $5.37 billion, surpassing the previous largest U.S. IPO of $1.75 billion by Venture Global Inc. in January [2]. - The IPO filing was submitted after a prolonged U.S. government shutdown that disrupted many companies' IPO plans, with Medline initially expecting to go public in November [2]. Financial Performance - For the nine months ending September 27, Medline reported a net profit of approximately $977 million and total revenue of about $20.6 billion, compared to a net profit of $911 million and revenue of approximately $18.7 billion in the same period the previous year [3]. Investment and Shareholder Structure - The company has secured approximately $2.35 billion in commitments from cornerstone investors, including Baillie Gifford, Capital Group, and Morgan Stanley's Counterpoint Global [5]. - Following the IPO, the Mills family will retain 17.8% of the voting rights, while Blackstone, Carlyle, and Hellman & Friedman will each hold 18% [7]. Market Context - The total amount raised from U.S. IPOs this year (excluding blank-check companies) is approximately $38.7 billion, which is expected to remain below the pre-pandemic average of nearly $50 billion per year [6]. - Major investment banks, including Goldman Sachs, Morgan Stanley, Bank of America, and JPMorgan, are involved in the IPO process, with the expected pricing to occur after market close on December 16 [8].